CYV — Ceryvyn Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapContrarian

Annual balance sheet for Ceryvyn Therapeutics, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.

	2022 June 30th	2023 June 30th	2024 June 30th	R2025 June 30th	2026 June 30th
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	fx Final	fx Final	fx Final	Final	Final
Cash
Cash and Equivalents
Cash and Short Term Investments	64.7	134	259	73.9	30
Net Total Accounts Receivable
Net Total Receivables	9.5	9.85	17.7	11.6	1.1
Prepaid Expenses
Total Current Assets	86.8	148	282	86.7	31.9
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.041	0.302	0.198	0	0
Other Long Term Assets
Total Assets	87	148	283	86.7	31.9
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	17.4	28.1	96.1	394	2.32
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.5	157	397	394	2.32
Common Stock
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	69.5	-8.78	-114	-307	29.6
Total Liabilities & Shareholders' Equity	87	148	283	86.7	31.9
Total Common Shares Outstanding